Simplex Trading’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$890 Buy
+1,267
New +$1.18K ﹤0.01% 8624
2025
Q3
Sell
-100
Closed -$174 9687
2025
Q2
$0 Buy
+100
New +$242 ﹤0.01% 9358
2024
Q4
Sell
-3,499
Closed -$13.2K 9225
2024
Q3
$13K Buy
3,499
+1,873
+115% +$7.89K ﹤0.01% 7011
2024
Q2
$6K Buy
1,626
+814
+100% +$3.5K ﹤0.01% 7778
2024
Q1
$3K Sell
812
-1,515
-65% -$7.11K ﹤0.01% 8276
2023
Q4
$10K Buy
2,327
+1,757
+308% +$6.84K ﹤0.01% 7435
2023
Q3
$1K Buy
570
+55
+11% +$221 ﹤0.01% 8367
2023
Q2
$2K Buy
+515
New +$2.37K ﹤0.01% 8456
2023
Q1
Sell
-1,018
Closed -$5.01K 9746
2022
Q4
$5K Buy
+1,018
New +$6.24K ﹤0.01% 8074

Other funds holding MXCT

Simplex Trading's MXCT Position: Q1 2026 in Review

Simplex Trading opened a new position in MaxCyte (MXCT) in Q1 2026: 1,267 shares worth $890. The stake represents ﹤0.01% of the portfolio and ranks #8624 among its holdings. This is a return to the name: Simplex Trading previously reported a position in MXCT as recently as Q2 2025.

Simplex Trading first reported a position in MXCT in Q4 2022 and has held it in 9 quarters since. The position peaked at $13K in Q3 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Simplex Trading held 1,267 shares of MaxCyte worth $890 as of Q1 2026.
  • MaxCyte was a new Simplex Trading position in Q1 2026.
  • MaxCyte made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8624 holding.
  • Simplex Trading first reported a position in MaxCyte in Q4 2022 and has held it in 9 quarters since.
  • Simplex Trading's MaxCyte position peaked at $13K in Q3 2024.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.